Folgen
Cory Berkland
Cory Berkland
Washington University in Saint Louis
Bestätigte E-Mail-Adresse bei wustl.edu
Titel
Zitiert von
Zitiert von
Jahr
Effects of nanomaterial physicochemical properties on in vivo toxicity
KL Aillon, Y Xie, N El-Gendy, CJ Berkland, ML Forrest
Advanced drug delivery reviews 61 (6), 457-466, 2009
9932009
Nanotechnology in vaccine delivery
LJ Peek, CR Middaugh, C Berkland
Advanced drug delivery reviews 60 (8), 915-928, 2008
7322008
Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment
A Fakhari, C Berkland
Acta biomaterialia 9 (7), 7081-7092, 2013
6302013
Nanoparticles for biomedical imaging
SK Nune, P Gunda, PK Thallapally, YY Lin, M Laird Forrest, CJ Berkland
Expert opinion on drug delivery 6 (11), 1175-1194, 2009
5472009
Precise control of PLG microsphere size provides enhanced control of drug release rate
C Berkland, M King, A Cox, KK Kim, DW Pack
Journal of controlled release 82 (1), 137-147, 2002
5102002
Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions
C Berkland, KK Kim, DW Pack
Journal of controlled release 73 (1), 59-74, 2001
4712001
Nanoparticle formulations in pulmonary drug delivery
MM Bailey, CJ Berkland
Medicinal research reviews 29 (1), 196-212, 2009
3842009
Practical considerations, challenges, and limitations of bioconjugation via azide–alkyne cycloaddition
CJ Pickens, SN Johnson, MM Pressnall, MA Leon, CJ Berkland
Bioconjugate chemistry 29 (3), 686-701, 2017
3102017
Microparticles
K Kim, DW Pack, C Berkland
US Patent 6,669,961, 2003
299*2003
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres
C Berkland, MJ Kipper, B Narasimhan, KK Kim, DW Pack
Journal of Controlled Release 94 (1), 129-141, 2004
2912004
PLG microsphere size controls drug release rate through several competing factors
C Berkland, K Kim, DW Pack
Pharmaceutical research 20, 1055-1062, 2003
2852003
Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering
M Singh, C Berkland, MS Detamore
Tissue Engineering Part B: Reviews 14 (4), 341-366, 2008
2612008
Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution
C Raman, C Berkland, KK Kim, DW Pack
Journal of Controlled Release 103 (1), 149-158, 2005
2612005
PLGA nanoparticle− peptide conjugate effectively targets intercellular cell-adhesion molecule-1
N Zhang, C Chittasupho, C Duangrat, TJ Siahaan, C Berkland
Bioconjugate chemistry 19 (1), 145-152, 2008
2472008
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
C Chittasupho, SX Xie, A Baoum, T Yakovleva, TJ Siahaan, CJ Berkland
European journal of pharmaceutical sciences 37 (2), 141-150, 2009
2322009
Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects
Q Wang, J Wang, Q Lu, MS Detamore, C Berkland
Biomaterials 31 (18), 4980-4986, 2010
2182010
Biodegradable colloidal gels as moldable tissue engineering scaffolds
Q Wang, L Wang, MS Detamore, C Berkland
Advanced Materials 20 (2), 236-239, 2008
2062008
Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly (D, L-lactide-co-glycolide)
C Berkland, DW Pack, KK Kim
Biomaterials 25 (25), 5649-5658, 2004
2002004
Flow behavior prior to crosslinking: The need for precursor rheology for placement of hydrogels in medical applications and for 3D bioprinting
JM Townsend, EC Beck, SH Gehrke, CJ Berkland, MS Detamore
Progress in polymer science 91, 126-140, 2019
1942019
Cell adhesion molecules for targeted drug delivery
AL Dunehoo, M Anderson, S Majumdar, N Kobayashi, C Berkland, ...
Journal of pharmaceutical sciences 95 (9), 1856-1872, 2006
1872006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20